Heart & Vascular Clinical Trials

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices (LEOPARD)

The goal of this study is to evaluate the ongoing safety and effectiveness of the AFX endovascular system compared to other similar FDA approved devices in the treatment of abdominal aortic aneurysm (AAA). Adults who have AAA and are appropriate for endovascular abdominal aortic aneurysm repair may be eligible to participate in this study.
Principal Investigators: Andrew Olinde, MD
Status: Currently recruiting participants by invitation only. Click here for additional information about this clinical trial.

The Phoenix Registry

The Phoenix Atherecomy System is an FDA approved device to treat peripheral artery disease (PAD). The purpose of this observational study is to collect data about the medical experiences and outcomes following the use of the Phoenix Atherectomy System. Adults who have PAD in their legs may be eligible to participate in this study.
Principal Investigator: Joseph Griffin, MD
Status: Currently recruiting participants by invitation only. Contact the Clinical Trials Office for additional information about this clinical trial.

Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST-CLI)

This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia (CLI) who are eligible for both treatment options.
Principal Investigator: Joseph Griffin, MD
Status: Currently recruiting participants by invitation only. Click here for additional information about this clinical trial.